These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3084143)

  • 1. Natural killer cell response to interferons.
    Abbud-Filho M; Ransil BJ; Kelley VE; Fiers W; Strom TB
    Clin Immunol Immunopathol; 1986 May; 39(2):264-76. PubMed ID: 3084143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells.
    Brunda MJ; Tarnowski D; Davatelis V
    Int J Cancer; 1986 May; 37(5):787-93. PubMed ID: 2422129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
    Platsoucas CD
    Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon alpha induces expression of the CD69 activation antigen in human resting NK cells, while interferon gamma and tumor necrosis factor alpha are ineffective.
    Gerosa F; Scardoni M; Tommasi M; Benati C; Snelli L; Gandini G; Libonati M; Tridente G; Carra G
    Int J Cancer; 1991 May; 48(3):473-5. PubMed ID: 1904052
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR; Kamber M; Peck R
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant human interferons on NK and K cell activities of gnotobiotic miniature swine.
    Kim YB; Chung TJ
    Prog Clin Biol Res; 1985; 181():329-32. PubMed ID: 3927308
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts.
    Bandyopadhyay S; Miller DS; Matsumoto-Kobayashi M; Clark SC; Starr SE
    Clin Exp Immunol; 1987 Feb; 67(2):372-82. PubMed ID: 2440628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interferon alpha 2 stimulation of target-binding by natural killer cells.
    Heidemann E; Weber J; Schmidt H; Reichmann U
    Klin Wochenschr; 1986 Oct; 64(20):1036-40. PubMed ID: 3465970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity.
    Takeda A; Minato N; Kano S
    Clin Exp Immunol; 1987 Nov; 70(2):354-63. PubMed ID: 2448073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased natural killer cell activity after prolonged administration of interferon in cancer patients.
    Bravo Cuellar A; Martin Ruiz JL; Orbach-Arbouys S
    Immunol Lett; 1985; 10(3-4):137-9. PubMed ID: 4044011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon and butyrate treatment leads to a decreased sensitivity of NK target cells to lysis by homologous but not by heterologous effector cells.
    Laskay T; Kiessling R
    Nat Immun Cell Growth Regul; 1986; 5(4):211-20. PubMed ID: 3095635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hydrocortisone on human natural killer activity and its modulation by beta interferon.
    Fuggetta MP; Graziani G; Aquino A; D'Atri S; Bonmassar E
    Int J Immunopharmacol; 1988; 10(6):687-94. PubMed ID: 3198305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
    Okabe M; Gomi K; Morimoto M; Nakamizo N
    Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of interferon on natural killer (NK) cells assessed by fluorescent probes and flow cytometry.
    McGinnes K; Chapman G; Penny R
    J Immunol Methods; 1988 Feb; 107(1):129-36. PubMed ID: 2449502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2.
    Ostensen ME; Thiele DL; Lipsky PE
    J Biol Response Mod; 1989 Feb; 8(1):53-61. PubMed ID: 2493514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase C treatment of certain human target cells reduces their susceptibility to NK lysis without affecting binding or sensitivity to lytic granules.
    Une C; Grönberg A; Axberg I; Jondal M; Orn A
    Cell Immunol; 1991 Mar; 133(1):127-37. PubMed ID: 1703925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
    J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
    Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
    J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of Leu-enkephalin and alpha-interferon in modulation of NK-activity of human peripheral blood lymphocytes.
    Gabrilovac J; Martin-Kleiner I; Ikić-Sutlić M; Osmak M
    Ann N Y Acad Sci; 1992 Apr; 650():140-5. PubMed ID: 1605472
    [No Abstract]   [Full Text] [Related]  

  • 20. A dual anti-tumor effect of a combination of interferon-alpha and 5-flurouracil or 2-chlorodeoxyadenosine on natural killer (NK) cell mediated cytotoxicity.
    Reiter Z; Ozes ON; Tomson S; Blatt LM; Taylor MW
    Adv Exp Med Biol; 1991; 309A():69-73. PubMed ID: 1686352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.